Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-059177
Filing Date
2025-06-13
Accepted
2025-06-13 08:57:50
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2517332d1_s3.htm S-3 229840
2 EXHIBIT 4.1 tm2517332d1_ex4-1.htm EX-4.1 112539
3 EXHIBIT 5.1 tm2517332d1_ex5-1.htm EX-5.1 9677
4 EXHIBIT 23.1 tm2517332d1_ex23-1.htm EX-23.1 2444
5 EX-FILING FEES tm2517332d1_ex-filingfees.htm EX-FILING FEES 18498
6 GRAPHIC tm2517332d1_ex23-1img001.jpg GRAPHIC 12140
7 GRAPHIC tm2517332d1_ex23-1img002.jpg GRAPHIC 8347
8 GRAPHIC tm2517332d1_ex5-1img01.jpg GRAPHIC 3048
9 GRAPHIC tm2517332d1_s3img01.jpg GRAPHIC 3846
  Complete submission text file 0001104659-25-059177.txt   412563
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-3 | Act: 33 | File No.: 333-288000 | Film No.: 251044850
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)